Meyer K, Smith R, Williams E C
Department of Medicine, University of Wisconsin, Madison 53706.
Thromb Haemost. 1987 Jun 3;57(3):345-8.
The effects of serum amyloid P component (SAP) and heparin on the thrombin-catalyzed formation of polymeric fibrin from purified fibrinogen were examined using a turbidometric method to quantify fibrin polymerization. SAP and heparin acted synergistically to inhibit the lateral aggregation of fibrin fibrils, resulting in the formation of fibrils with a smaller mass to length ratio. Heparin did not enhance the incorporation of SAP into fibrin clots, and the effect of heparin and SAP did not seem to be related to inhibition of thrombin or of fibrinopeptide release. The evidence suggests that a soluble complex of SAP and heparin inhibits fibrin polymerization.
采用比浊法测定纤维蛋白原聚合反应,研究血清淀粉样蛋白P成分(SAP)和肝素对凝血酶催化纯化纤维蛋白原形成聚合纤维蛋白的影响。SAP和肝素协同作用抑制纤维蛋白原纤维的横向聚集,导致形成质量与长度比更小的纤维。肝素不会增强SAP掺入纤维蛋白凝块,肝素和SAP的作用似乎与抑制凝血酶或纤维蛋白肽释放无关。证据表明,SAP和肝素的可溶性复合物可抑制纤维蛋白聚合。